• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY MEGATRON; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY MEGATRON; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0025426096
Device Problem Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/04/2021
Event Type  Injury  
Event Description
It was reported that stent migrate to the proximal left main.The 90% stenosed target lesion was located in the moderately calcified and mildly tortuous left main coronary artery.A 4.50 x 24mm synergy megatron stent was selected for a procedure.While inflation the stent the balloon only filled with contrast on the distal part of the balloon, and the stent moved from the planed position in to the proximal left main.The stent placement was plan b and the physician was happy with the treatment.The procedure was completed successfully with this device.There were no patient complications and the patient was good post procedure.It was reported that stent migrate to the proximal left main.The 90% stenosed target lesion was located in the moderately calcified and mildly tortuous left main coronary artery.A 4.50 x 24mm synergy megatron stent was selected for a procedure.While inflation the stent the balloon only filled with contrast on the distal part of the balloon, and the stent moved from the planed position in to the proximal left main.The stent placement was plan b and the physician was happy with the treatment.The procedure was completed successfully with this device.There were no patient complications and the patient was good post procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY MEGATRON
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12605150
MDR Text Key276451705
Report Number2134265-2021-12649
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeNO
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 10/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/10/2022
Device Lot Number0025426096
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/05/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/10/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-